Elanco Animal Health (ELAN) Receivables - Net (2017 - 2026)

Elanco Animal Health has disclosed Receivables - Net across 10 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Receivables - Net rose 8.9% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (up 8.9% YoY), while the FY2025 annual figure was $873.0 million, up 8.45% from the prior year.
• Receivables - Net came in at $1.1 billion for Q2 2026 at Elanco Animal Health, down from $1.1 billion in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.1 billion in Q1 2026 to a low of $797.0 million in Q4 2022.
• Average Receivables - Net over 5 years is $934.1 million, with a median of $943.0 million recorded in 2022.
• Year-over-year, Receivables - Net declined 14.15% in 2022 and climbed 13.31% in 2023.
• Over 5 years, Receivables - Net stood at $797.0 million in 2022, then grew by 5.65% to $842.0 million in 2023, then fell by 4.39% to $805.0 million in 2024, then gained by 8.45% to $873.0 million in 2025, then grew by 23.37% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $873.0 million in Q4 2025.